Prokidney (PROK) Cash from Financing Activities (2021 - 2026)

Prokidney's (PROK) quarterly Cash from Financing Activities came in at $215000.0 in Q1 2026, up 1891.67% year-on-year from $10795.0 in Q1 2025, and down 98.78% on a QoQ basis from $17.6 million in Q4 2025.

Prokidney (PROK) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Cash from Financing Activities data on file, last reported at $215000.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 1891.67% year-over-year to $215000.0 in Q1 2026; TTM through Mar 2026 was $25.8 million, a 82.14% decrease from a year earlier, with the FY2025 full-year figure at $25.6 million, down 82.29% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $215000.0, down from $17.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PROK reached as high as $507.5 million in Q3 2022 and fell as low as -$9.5 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $41.7 million across 5 years, with a median of $123000.0 in 2024.
  • Across the five-year window, Cash from Financing Activities slumped 118800.0% in 2023 and jumped 1075807.69% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$8000.0 in 2022, then slumped by 118800.0% to -$9.5 million in 2023, then surged by 101.29% to $123000.0 in 2024, then jumped by 14236.59% to $17.6 million in 2025, then sank by 98.78% to $215000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $215000.0 in Q1 2026, $17.6 million in Q4 2025, and $8.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 30.14 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 53,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 68.63 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 238.74 Mn
10 Prokidney 96.00 Mn 96.00 Mn - 215,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 215,000.00
Mar 31, 2026 215,000.00
Dec 31, 2025 17.63 Mn
Dec 31, 2025 17.63 Mn
Sep 30, 2025 7.96 Mn
Sep 30, 2025 7.96 Mn
Jun 30, 2025 -14,000.00
Jun 30, 2025 -14,000.00
Mar 31, 2025 -12,000.00
Mar 31, 2025 -12,000.00
Dec 31, 2024 123,000.00
Dec 31, 2024 123,000.00
Sep 30, 2024 4.46 Mn
Sep 30, 2024 4.46 Mn
Jun 30, 2024 139.84 Mn
Jun 30, 2024 139.84 Mn
Mar 31, 2024 -13,000.00
Mar 31, 2024 -13,000.00
Dec 31, 2023 -9.51 Mn
Dec 31, 2023 -9.51 Mn